참고문헌
- Kanis, J.A., Oden, A., Johnell, O., De Laet, C., Jonsson, B., Oglesby, A.K. The components of excess mortality after hip fracture. Bone 32: 468, 2003. https://doi.org/10.1016/S8756-3282(03)00061-9
- Melton, L.J., 3rd, Atkinson, E.J., O'Connor, M.K., et al. Bone density and fracture risk in men. J Bone Miner Res 13: 1915, 1998. https://doi.org/10.1359/jbmr.1998.13.12.1915
- Johnell, O. and Kanis, J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17: 1726, 2006. https://doi.org/10.1007/s00198-006-0172-4
- Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugal, N., Yamamoto, M., Nagata, N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone. 18: 9-14, 1996. https://doi.org/10.1016/8756-3282(95)00426-2
- Abrahamsen, B. Bisphosphonate adverse effects, lessons from large databases. Curr Opin Rheumatol. 22(4):404-409, 2010. https://doi.org/10.1097/BOR.0b013e32833ad677
- Kwak, H.B., Kim, J.H., Kim, D.J., Kwon, Y.M., Oh, J., Kim, Y.K. Effect of water extract of deer antler in osteoclast differentiation. Korean J Oriental Physiology & pathology. 22: 891-895, 2008.
- 정연태, 최윤홍, 송정훈, 이창훈, 오재민. 두충의 물 추출물이 파골세포의 분화에 미치는 영향. 동의생리병리학회지 23: 613-618, 2009.
- Deriu, A., Zanetti, S., Sechi, L.A., Marongiu, B., Piras, A., Porcedda, S., Tuveri, E. Antimicrobial activity of Inula helenium L. essential oil against Gram-positive and Gram-negative bacteria and Candida spp. Int J Antimicrob Agents. 31(6):588-590, 2008. https://doi.org/10.1016/j.ijantimicag.2008.02.006
- Seo, J.Y., Lim, S.S., Kim, J.R., Lim, J.S., Ha, Y.R., Lee, I.A., Kim, E.J., Park, J.H., Kim, J.S. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium. Phytother Res. 22(11):1500-1505, 2008. https://doi.org/10.1002/ptr.2521
- Dorn, D.C., Alexenizer, M., Hengstler, J.G., Dorn, A. Tumor cell specific toxicity of Inula helenium extracts. Phytother Res. 20(11):970-980, 2006. https://doi.org/10.1002/ptr.1991
- Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclast differentiation and activation. Nature. 423: 337-342, 2003. https://doi.org/10.1038/nature01658
- Rao, A., Luo, C., Hogan, P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15: 707-747, 1997. https://doi.org/10.1146/annurev.immunol.15.1.707
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- Vestergaard, P., Schwartz, K., Pinholt, E.M., Rejnmark, L., Mosekilde, L. Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study. Calcif Tissue Int. 86(5):335-342, 2010. https://doi.org/10.1007/s00223-010-9349-0
- Watts, N.B., Diab, D.L. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab. 95(4):1555-1565, 2010. https://doi.org/10.1210/jc.2009-1947
- Shimizu, H., Nakagami, H., Tsukamoto, I., Morita, S., Kunugiza, Y., Tomita, T., Yoshikawa, H., Kaneda, Y., Ogihara, T., Morishita, R. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Ther. 13(12):933-941, 2006. https://doi.org/10.1038/sj.gt.3302711